Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2581
-0.0658-20.31%
Post-market: 0.26000.0019+0.74%19:59 EDT
Volume:2.02M
Turnover:572.63K
Market Cap:66.39M
PE:-0.86
High:0.3200
Open:0.3150
Low:0.2500
Close:0.3239
Loading ...

Adaptimmune Therapeutics PLC reports results for the quarter - Earnings Summary

Reuters
·
14 Nov 2024

Adaptimmune: Estimates Pre-Tax Costs of Workforce Reduction for Employee Severance,Other Employee-Related Costs May Be in Region of $9-11 Mln

THOMSON REUTERS
·
14 Nov 2024

Adaptimmune - Planning 33% Reduction in Workforce, Believes Restructuring Plan to Result in About $300 Mln in Aggregate Cost Savings Over Next 4 Yrs

THOMSON REUTERS
·
14 Nov 2024

Adaptimmune Therapeutics to Cut Workforce by 33%

Dow Jones
·
14 Nov 2024

Adaptimmune trading resumes

TIPRANKS
·
14 Nov 2024

Adaptimmune Therapeutics Q3 2024 GAAP EPS $(0.07) Beats $(0.13) Estimate, Sales $40.901M Beat $11.172M Estimate

Benzinga
·
14 Nov 2024

Adaptimmune trading halted, news pending

TIPRANKS
·
14 Nov 2024

BUZZ-Adaptimmune up as cancer therapy meets main goal in mid-stage study

Reuters
·
13 Nov 2024

Adaptimmune reports positive data in mid-stage trial of its sarcoma treatment

seekingalpha
·
13 Nov 2024

BRIEF-Adaptimmune Therapeutics PLC Lete-Cel Achieves Primary Endpoint In Pivotal Trial

Reuters
·
13 Nov 2024

Adaptimmune Therapeutics Plc: Lete-Cel Achieves Primary Endpoint in Pivotal Trial

THOMSON REUTERS
·
13 Nov 2024

Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial

Newsfile
·
13 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 Nov 2024

Adaptimmune Therapeutics PLC expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

European Equities Traded in the US as American Depositary Rise Thursday

MT Newswires Live
·
08 Nov 2024

European Equities Traded in the US as American Depositary Receipts Edge Higher Tuesday

MT Newswires Live
·
06 Nov 2024

Adaptimmune to Participate in Scientific and Medical Conferences this November and December

Newsfile
·
05 Nov 2024

BRIEF-Adaptimmune Therapeutics gets Nasdaq notice for non-compliance with minimum bid price

Reuters
·
02 Nov 2024

Adaptimmune Therapeutics Plc - Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price

THOMSON REUTERS
·
02 Nov 2024

European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday

MT Newswires Live
·
01 Nov 2024